trending Market Intelligence /marketintelligence/en/news-insights/trending/s8s9iz_zp_rkqzer7dhxdw2 content esgSubNav
In This List

Oncobiologics names director

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Infographic

Infographic: The Big Picture 2023 Sustainability Outlook

Blog

The Big Picture for 2023: Assessing Investment Trends and the Impact of Investor Activism


Oncobiologics names director

Oncobiologics Inc. appointed Joerg Windisch as director, effective March 23.

He was appointed to fill the vacancy created by Yezan Haddadin's resignation from the board, the company said March 27 in an SEC filing.

Windisch is currently COO of Polpharma Biologics.

Cranbury, N.J.-based Oncobiologics is a clinical-stage biopharmaceutical company which focuses on developing biosimilars in immunology and oncology disease areas.